Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461680 | SCV000546588 | uncertain significance | Gastrointestinal stromal tumor | 2023-12-21 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 718 of the PDGFRA protein (p.Arg718Gln). This variant is present in population databases (rs367722824, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with PDGFRA-related conditions. ClinVar contains an entry for this variant (Variation ID: 407393). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PDGFRA protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV003476046 | SCV004200974 | uncertain significance | Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004943874 | SCV005471007 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-12-08 | criteria provided, single submitter | clinical testing | The p.R718Q variant (also known as c.2153G>A), located in coding exon 14 of the PDGFRA gene, results from a G to A substitution at nucleotide position 2153. The arginine at codon 718 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |